Salivary prognostic bacterial signatures associated with survival outcomes and recurrence risk in head and neck squamous cell carcinoma
Abstract
Background: Alterations in the oral microbiota are increasingly recognized as an integral component of the tumor microenvironment, forming a clinically relevant oncobiome that may modulate tumorigenesis, therapeutic response, and patient prognosis in head and neck squamous cell carcinoma (HNSCC).
Methods: In this prospective study, we characterized the salivary microbiome of 124 Spanish HNSCC patients (86 laryngeal and 38 pharyngeal carcinomas) and 66 healthy controls from northern Spain using 16S rRNA gene sequencing. Microbial community structure, differential abundance, and associations with tumor site and treatment received were analyzed using ANCOM-BC, while prognostic associations were assessed through univariable and multivariable Cox regression models and survival analyses.
Results: Distinct microbial community profiles were observed between patients and controls, revealing pronounced site-specific dysbiosis between pharyngeal and laryngeal tumors. Microbiome composition also varied according to treatment modality. Chemoradiotherapy induced a marked remodeling of the oncobiome, characterized by a post-treatment enrichment of Lactobacillus . More importantly, a specific 10-bacteria salivary signature was significantly associated with poorer survival outcomes. including disease-specific survival (DSS), overall survival (OS), and disease-free survival (DFS). This 10-bacterial signature remained independently associated with poor prognosis in multivariable analysis for DSS (HR = 6.215; p < 0.001), OS (HR = 5.417; p < 0.001), and DFS (HR = 6.842; p < 0.001), after adjustment for established clinicopathological variables. Furthermore, we identified tumor site–specific prognostic taxa within the oral microbiome of HNSCC patients. The presence of putative Prevotella , Porphyromonas and Fusobacterium species specifically and significantly correlated with improved DSS, OS and DFS in pharyngeal carcinomas, whereas putative Stomatobaculum longum and Dialister were associated with favorable survival outcomes in laryngeal carcinomas.
Conclusions: Our findings reveal distinct oral microbial patterns linked to HNSCC prognosis and recurrence risk, demonstrating that the salivary microbiome may represent a source of non-invasive, dynamic biomarkers for risk stratification and personalized management. The identification of tumor site–specific bacterial signatures associated with both favorable and unfavorable survival outcomes supports the concept of an anatomically contextualized oncobiome, although validation in independent cohorts and higher-resolution microbiome studies will be required before clinical implementation.
Related
- Development and External Evaluation of Hypoxia-Related Prognostic Signatures in Head and Neck Squamous Cell Carcinoma.
- AI-guided deep visual proteomics reveals recurrence-associated morpho-molecular signatures within triple-negative breast cancers
- Preoperative systemic immunothrombotic state class is associated with microvascular invasion and early recurrence after curative resection for hepatocellular carcinoma
- Single-cell and bulk transcriptome-based identification of myeloid-derived suppressor cell-associated immune evasion signatures and a prognostic model for gastric cancer.
- Effectiveness of male partner treatment in reducing recurrence of bacterial vaginosis: a systematic review and meta-analysis
BibTeX
@article{grandadiaz2026salivary,
title = {{Salivary prognostic bacterial signatures associated with survival outcomes and recurrence risk in head and neck squamous cell carcinoma}},
author = {Rocío Granda-Díaz and Natalia Molinero and Mario Sánchez-Canteli and Saúl Álvarez-Teijeiro and Alex Mira and Eva Allonca and Víctor Quesada and Abelardo Margolles and Pablo Martínez-Camblor and Ernesto Martín-Guillermo and Susana Delgado and Juan P. Rodrigo and Juana M. García-Pedrero},
journal = {Microbiome},
year = {2026},
month = oct,
doi = {10.1186/s40168-026-02548-w},
url = {https://link.springer.com/10.1186/s40168-026-02548-w},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Salivary prognostic bacterial signatures associated with survival outcomes and recurrence risk in head and neck squamous cell carcinoma
AU - Rocío Granda-Díaz
AU - Natalia Molinero
AU - Mario Sánchez-Canteli
AU - Saúl Álvarez-Teijeiro
AU - Alex Mira
AU - Eva Allonca
AU - Víctor Quesada
AU - Abelardo Margolles
AU - Pablo Martínez-Camblor
AU - Ernesto Martín-Guillermo
AU - Susana Delgado
AU - Juan P. Rodrigo
AU - Juana M. García-Pedrero
PY - 2026
DA - 2026/10/09
JO - Microbiome
DO - 10.1186/s40168-026-02548-w
UR - https://link.springer.com/10.1186/s40168-026-02548-w
AB - Background: Alterations in the oral microbiota are increasingly recognized as an integral component of the tumor microenvironment, forming a clinically relevant oncobiome that may modulate tumorigenesis, therapeutic response, and patient prognosis in head and neck squamous cell carcinoma (HNSCC). Methods: In this prospective study, we characterized the salivary microbiome of 124 Spanish HNSCC patients (86 laryngeal and 38 pharyngeal carcinomas) and 66 healthy controls from northern Spain using 16S rRNA gene sequencing. Microbial community structure, differential abundance, and associations with tumor site and treatment received were analyzed using ANCOM-BC, while prognostic associations were assessed through univariable and multivariable Cox regression models and survival analyses. Results: Distinct microbial community profiles were observed between patients and controls, revealing pronounced site-specific dysbiosis between pharyngeal and laryngeal tumors. Microbiome composition also varied according to treatment modality. Chemoradiotherapy induced a marked remodeling of the oncobiome, characterized by a post-treatment enrichment of Lactobacillus . More importantly, a specific 10-bacteria salivary signature was significantly associated with poorer survival outcomes. including disease-specific survival (DSS), overall survival (OS), and disease-free survival (DFS). This 10-bacterial signature remained independently associated with poor prognosis in multivariable analysis for DSS (HR = 6.215; p < 0.001), OS (HR = 5.417; p < 0.001), and DFS (HR = 6.842; p < 0.001), after adjustment for established clinicopathological variables. Furthermore, we identified tumor site–specific prognostic taxa within the oral microbiome of HNSCC patients. The presence of putative Prevotella , Porphyromonas and Fusobacterium species specifically and significantly correlated with improved DSS, OS and DFS in pharyngeal carcinomas, whereas putative Stomatobaculum longum and Dialister were associated with favorable survival outcomes in laryngeal carcinomas. Conclusions: Our findings reveal distinct oral microbial patterns linked to HNSCC prognosis and recurrence risk, demonstrating that the salivary microbiome may represent a source of non-invasive, dynamic biomarkers for risk stratification and personalized management. The identification of tumor site–specific bacterial signatures associated with both favorable and unfavorable survival outcomes supports the concept of an anatomically contextualized oncobiome, although validation in independent cohorts and higher-resolution microbiome studies will be required before clinical implementation.
SN - 2049-2618
ER -